Quick answer: HPA axis dysregulation — commonly called “adrenal fatigue” — is not adrenal gland failure but a disrupted cortisol signaling pattern involving the hypothalamus-pituitary-adrenal feedback loop. It affects an estimated 67% of adults experiencing chronic stress and produces a characteristic pattern: morning fatigue despite sleep, afternoon energy crash, evening second wind, poor stress resilience, salt cravings, and immune dysregulation. The gold standard assessment is a 4-point salivary cortisol test plus DHEA-S. The evidence-based protocol addresses the root cause — not just symptoms — through sleep architecture repair, blood sugar stabilization, adaptogen therapy (ashwagandha KSM-66, rhodiola rosea, phosphatidylserine), and gradual HPA axis retraining over 3-6 months.
What Is the HPA Axis and Why Does It Dysregulate?
The hypothalamic-pituitary-adrenal (HPA) axis is the body’s primary neuroendocrine stress response system. When the brain perceives a threat — physical, psychological, or metabolic — the hypothalamus releases corticotropin-releasing hormone (CRH), which signals the anterior pituitary to release adrenocorticotropic hormone (ACTH), which in turn stimulates the adrenal cortex to produce cortisol. In a healthy system, elevated cortisol feeds back to the hypothalamus and pituitary to shut off further CRH and ACTH production — the classic negative feedback loop. The system is designed for acute, time-limited stress, after which it resets to baseline.
In modern chronic stress — sustained psychological pressure, poor sleep, ultraprocessed diets, sedentary lifestyle, and constant low-grade inflammation — the HPA axis never fully resets. The initial response is hypercortisolism (elevated cortisol throughout the day), which over months to years shifts to a blunted, dysregulated pattern as the feedback system loses sensitivity. This is what Tomas Guilliams and other researchers describe as HPA axis dysregulation — not adrenal gland exhaustion, but a recalibration of the entire signaling axis that produces the characteristic flat cortisol curve or inverted pattern.
The term “adrenal fatigue” popularized by James Wilson in 1998 has been controversial in conventional medicine because it implies adrenal gland failure (Addison’s disease), which is a distinct and serious autoimmune condition. Functional medicine has largely moved toward “HPA axis dysregulation” as the more accurate term — acknowledging that the dysfunction is systemic and neuroendocrine rather than purely adrenal. The clinical presentation is real and measurable; the nomenclature debate should not obscure the significant quality-of-life impairment and downstream metabolic consequences of cortisol signaling disruption.
The major drivers of HPA axis dysregulation in the 21st century are: chronic psychological stress without adequate recovery; sleep deprivation and disrupted circadian rhythm (the HPA axis is fundamentally circadian — cortisol should peak at 8am and reach its nadir at midnight, and any disruption to this rhythm impairs the entire axis); chronic inflammation (IL-6, TNF-α, and other inflammatory cytokines are potent CRH/ACTH stimulators); blood sugar dysregulation (reactive hypoglycemia triggers cortisol as a glucose counter-regulatory hormone — frequent blood sugar swings produce constant low-level HPA activation); overtraining without recovery; and gut dysbiosis (the gut-brain axis directly modulates CRH production, and dysbiosis creates inflammatory signals that sustain HPA activation).
The Cortisol Awakening Response and Dysregulation Patterns
The cortisol awakening response (CAR) is one of the most clinically informative aspects of HPA axis function. In a healthy individual, cortisol rises 50-160% within 20-30 minutes of waking — a sharp, deliberate spike that prepares the immune system, mobilizes energy, and activates alertness for the coming day. This morning spike then declines gradually throughout the day, reaching its lowest point at midnight before rising again in the pre-dawn hours (2-4am) in preparation for waking. The entire pattern is tightly coordinated with the circadian clock via the suprachiasmatic nucleus.
In HPA axis dysregulation, this pattern degrades in characteristic ways. In early-stage or acute stress dysregulation, the curve is flattened upward — cortisol is elevated throughout the day and evening, producing insomnia, anxiety, hyperarousal, and suppressed immune function. In chronic or advanced dysregulation, the curve inverts — morning cortisol is blunted (difficulty waking, morning fatigue, inability to function without caffeine) while evening cortisol is elevated (second wind, difficulty sleeping, racing thoughts at night). The CAR specifically — the 30-minute post-waking spike — loses its amplitude, and this blunted CAR is associated with increased inflammatory markers, increased sick days, reduced cognitive performance, and burnout syndrome in occupational medicine literature.
Waking cortisol and the CAR are also powerfully modulated by perceived stress, sleep quality, and anticipatory thoughts about the coming day. Studies by Pruessner and others (2003, Psychoneuroendocrinology) showed that individuals who woke up with a sense of workload pressure and time urgency had significantly higher and more protracted CAR than those who woke without immediate stressors — even before a single external event had occurred. This underscores that HPA axis dysregulation is a central nervous system problem as much as an endocrine one.
Clinical Presentation: Recognizing the Pattern
HPA axis dysregulation produces a recognizable symptom cluster that distinguishes it from other fatigue and energy dysregulation syndromes. The most specific features of the dysregulated cortisol pattern include:
Morning fatigue despite adequate sleep — waking unrefreshed, requiring 1-2 hours and significant caffeine to feel functional. This reflects blunted morning cortisol and CAR failure. In contrast to hypothyroidism (which causes persistent all-day fatigue) or depression (which often features early morning awakening with inability to return to sleep), HPA dysregulation specifically causes worst energy in the first 2 hours after waking with gradual improvement as the day progresses.
Afternoon crash between 2-4pm — a predictable energy dip that corresponds to the normal cortisol nadir. In healthy individuals, this dip is mild; in HPA dysregulation, it becomes incapacitating. The strong craving for caffeine or sugar in the mid-afternoon is a classic marker. Blood sugar dysregulation amplifies this — if morning nutrition is poor (high-carbohydrate, low-protein breakfast), the blood sugar crash compounds the cortisol nadir.
Evening second wind and insomnia — paradoxical energy surge beginning around 9-11pm, coinciding with elevated evening cortisol in the dysregulated pattern. The individual may feel most alert and creative at night, making it difficult to wind down for sleep. Once asleep, they may wake at 2-4am (corresponding to the pre-dawn cortisol rise that is occurring too early or too intensely).
Orthostatic symptoms — dizziness or lightheadedness on standing (orthostatic hypotension), driven by aldosterone dysregulation secondary to HPA dysfunction. Cortisol supports vascular tone and aldosterone secretion; when cortisol is low in the morning, blood pressure regulation on standing is impaired. This is one of the more objective, measurable features of HPA dysregulation.
Salt and sweet cravings — salt craving reflects aldosterone/sodium dysregulation; sweet craving reflects blood sugar dysregulation and adrenal reliance on glucose counter-regulation. These are metabolic distress signals from the HPA system, not character deficits or willpower failures.
Immune dysregulation — frequent infections that take longer than normal to clear, or alternatively, overactive immune responses (autoimmune flares, allergies, histamine reactivity). Cortisol is a powerful immune modulator — both too much cortisol (suppresses immune function) and dysregulated cortisol (erratic immune signaling) impair normal immune surveillance. The connection to recurrent infections or autoimmune activity is frequently a clinical clue to underlying HPA dysregulation.
Cognitive dysfunction — “brain fog,” impaired working memory, reduced word-finding, and difficulty concentrating are consistent features. Chronic elevated cortisol is neurotoxic to the hippocampus — Sapolsky’s research demonstrated cortisol-driven hippocampal atrophy in chronically stressed primates, and human MRI studies confirm reduced hippocampal volume in individuals with chronic stress exposure and high cortisol. Cognitive symptoms are often among the most distressing and motivating for patients seeking functional assessment.
Downstream Effects on Other Hormonal Systems
The HPA axis does not operate in isolation — cortisol dysregulation predictably disrupts every other hormonal axis, which is why patients with HPA dysregulation rarely present with one problem.
Pregnenolone steal and sex hormone suppression: Pregnenolone is the master precursor for all steroid hormones. Under chronic cortisol demand, the enzymatic machinery preferentially converts pregnenolone to cortisol at the expense of downstream sex hormones — progesterone, DHEA, testosterone, and estrogen. This creates the clinical picture of simultaneous HPA dysregulation, low progesterone, low testosterone, and low DHEA even in the absence of primary sex hormone dysfunction. Treating the HPA axis first allows the pregnenolone pool to restore sex hormone production without direct sex hormone supplementation.
Thyroid suppression: Elevated cortisol impairs thyroid function through multiple mechanisms. Cortisol reduces TSH secretion from the pituitary, decreases conversion of T4 to active T3 (while increasing conversion to inactive reverse T3), and reduces thyroid receptor sensitivity. A woman with TSH of 2.5, normal free T4, low-normal free T3, elevated reverse T3, and a full constellation of hypothyroid symptoms may have HPA dysregulation driving apparent thyroid dysfunction rather than primary thyroid disease. Normalizing cortisol rhythm often produces significant improvement in thyroid lab markers and symptoms without thyroid medication.
Insulin resistance and metabolic syndrome: Cortisol is a counter-regulatory hormone to insulin — it raises blood glucose by stimulating gluconeogenesis, promoting glycogen breakdown, and inducing insulin resistance in peripheral tissues. Chronic cortisol elevation is one of the most potent drivers of insulin resistance, particularly visceral fat accumulation. The characteristic belly fat of chronic stress is mechanistically cortisol-driven, mediated by high cortisol receptor density in visceral adipose tissue. Addressing HPA dysregulation is often required for meaningful metabolic improvement in metabolic syndrome patients who have failed dietary interventions alone.
Gut microbiome disruption: The gut-brain axis operates bidirectionally, and HPA dysregulation profoundly impacts gut function. Elevated CRH directly increases intestinal permeability (leaky gut) and promotes mast cell degranulation in the gut wall. Reduced mucosal IgA from cortisol dysregulation impairs the first line of gut immune defense. Motility changes (IBS is stress-sensitive via CRH receptors in the gut) and microbiome composition shifts are well-documented in chronic stress states. This gut-HPA connection means that HPA axis treatment and gut restoration (the 4R protocol) are frequently synergistic and should be considered complementary rather than sequential.
Testing the HPA Axis: The Right Tests in the Right Sequence
4-point salivary cortisol testing is the foundation of HPA axis assessment. Saliva cortisol reflects free (biologically active) cortisol rather than total cortisol (which includes protein-bound cortisol measured in serum). Collection at 4 time points — waking (immediately upon waking), 30 minutes post-waking (to capture the CAR), noon, 4pm, and bedtime — maps the full diurnal cortisol curve and identifies pattern type: high-flat (early stage), low-flat (chronic stage), inverted, or broken curve variants. This level of resolution is not available with a single morning serum cortisol draw, which is why standard lab testing consistently fails to detect HPA dysregulation.
DUTCH Complete test (Dried Urine Test for Comprehensive Hormones) adds critical additional layers: free cortisol and cortisone metabolites (reflecting total cortisol production rather than just free cortisol levels), cortisol awakening response calculation from first and second morning voids, DHEA and DHEA-S, metabolized androgens and estrogens, and the cortisol:cortisone ratio (which reflects 11β-HSD enzyme activity — relevant for understanding the tissue-level cortisol effect beyond blood levels). DUTCH provides the most complete picture of HPA function and is the preferred test when resources allow a single comprehensive evaluation.
DHEA-S serum level is the single most accessible and cost-effective marker for HPA reserve. DHEA (dehydroepiandrosterone) is produced in the adrenal cortex alongside cortisol and declines as HPA capacity is chronically overwhelmed. Optimal DHEA-S levels are: women 150-350 mcg/dL (ages 25-50); men 300-500 mcg/dL. Conventional reference ranges extend lower (often flagging normal below 35-65 mcg/dL), but functional medicine targets the mid-normal range for age for metabolic and immune optimization. DHEA-S below 100 mcg/dL in women under 50 warrants HPA axis investigation.
What NOT to use for HPA assessment: A single morning serum cortisol (misses pattern, only captures one time point at which cortisol is normally highest); 24-hour urine cortisol (averages the full day and masks the critical diurnal pattern); serum ACTH stimulation test (detects Addison’s disease, not HPA dysregulation — the axis can still respond to exogenous ACTH even when the signaling pattern is disrupted).
The Evidence-Based HPA Restoration Protocol
Restoration of HPA axis function requires systematic address of every driver — there is no single supplement or intervention that corrects HPA dysregulation in isolation. The protocol operates in three simultaneous domains: circadian rhythm repair, blood sugar stabilization, and targeted nutritional/adaptogen support.
Domain 1: Circadian rhythm repair — the HPA axis is a circadian organ, and recovery is impossible without anchoring the circadian clock. The protocol: consistent wake time every day (including weekends) within 30 minutes of the same time; bright light exposure within 10 minutes of waking (10,000 lux lightbox or outdoor morning light) to calibrate the suprachiasmatic nucleus and amplify the cortisol awakening response; blue-light elimination after 8pm (blue-light-blocking glasses or device night mode) to prevent melatonin suppression that delays sleep onset; room temperature 65-68°F for optimal sleep architecture; no screens or cognitively activating content within 60 minutes of bed. These circadian anchors are not optional adjuncts — they are the foundation on which everything else depends.
Domain 2: Blood sugar stabilization — reactive hypoglycemia is one of the most common and most overlooked HPA stressors. Each blood sugar drop triggers a cortisol surge as a glucose counter-regulatory response, which adds to total daily cortisol burden. The correction: minimum 30g of protein at breakfast within 60 minutes of waking (prevents the cortisol spike from fasting stress), no high-glycemic breakfast foods (refined carbohydrates, juice, sweet coffee drinks), protein and fat with every meal and snack, target 3-4 hours between meals without snacking to allow insulin to clear, and eliminate liquid calories with glucose/fructose content. Continuous glucose monitoring (CGM) for 2-4 weeks provides powerful biofeedback on the cortisol-glucose relationship that no other tool can replicate.
Domain 3: Targeted adaptogen and nutritional support:
Ashwagandha (Withania somnifera) KSM-66 extract, 300-600mg/day: The most rigorously studied adaptogen for cortisol normalization. The landmark Chandrasekhar 2012 RCT (n=64, 60 days) showed KSM-66 at 300mg twice daily reduced serum cortisol by 27.9%, reduced PSS (Perceived Stress Scale) by 44%, improved sleep quality, and reduced morning fatigue versus placebo. The Choudhary 2017 RCT confirmed stress and anxiety reduction. The KSM-66 form is superior to WS 1.5 (Sensoril) for morning energy restoration; Sensoril is better for evening cortisol reduction and sleep. Dose: 600mg KSM-66 as a single morning dose for HPA restoration; can split morning/evening if cortisol is elevated throughout the day.
Rhodiola rosea (SHR-5 extract), 200-400mg/day: Rhodiola’s primary adaptogenic mechanism is activation of the stress-response proteins Hsp70 and GR (glucocorticoid receptor modulation) — it works at a different point in the HPA cascade than ashwagandha. Darbinyan 2000 and Spasov 2000 trials showed significant improvement in mental fatigue, concentration, and work capacity under stress conditions. Rhodiola is particularly indicated for burnout syndrome and cognitive fatigue components of HPA dysregulation. Important: Rhodiola is mildly stimulating and should be taken in the morning only — bedtime dosing worsens insomnia. Start at 200mg for 2 weeks before increasing.
Phosphatidylserine (PS), 400-800mg/day: Phosphatidylserine is the only supplement with FDA-approved structure-function claim language for reducing cortisol. Monteleone 1992 trial demonstrated 800mg PS significantly blunted ACTH and cortisol response to exercise stress. Benton 2001 showed improved mood and reduced cortisol response to mental stress. PS works by improving glucocorticoid receptor sensitivity — essentially making the HPA axis more responsive to cortisol’s own negative feedback signal, shortening the stress response. This is mechanistically distinct from adaptogens and highly complementary. Optimal timing: 400mg with breakfast and 400mg in the afternoon during periods of peak stress.
Magnesium glycinate, 400mg nightly: Magnesium deficiency (affecting approximately 68% of adults) directly impairs HPA axis regulation — magnesium modulates NMDA receptors in the hypothalamus that control CRH release. Hypermagnesemia blunts cortisol; hypomagnesemia amplifies it. A vicious cycle operates: stress depletes magnesium, magnesium depletion impairs stress regulation, which further depletes magnesium. Glycinate form is most bioavailable and least likely to cause GI side effects. Nightly dosing capitalizes on magnesium’s sleep-promoting GABA effects and its role in restorative sleep architecture.
Vitamin C, 1,000-2,000mg/day in divided doses: The adrenal gland has the highest vitamin C concentration of any organ. Vitamin C is required for cortisol synthesis (ironic given its role in stress response — chronic stress depletes vitamin C while the adrenal gland simultaneously requires it for cortisol production). Vitamin C also reduces cortisol response to acute stress: Peters 2001 RCT showed 1,500mg/day vitamin C reduced post-marathon cortisol by 30% and reduced muscle soreness and URTI incidence — a model for the cortisol-buffering effect in any high-stress context.
B5 (pantothenic acid), 500-1,000mg/day: Pantothenic acid is required for CoA synthesis in the adrenal steroidogenesis pathway. Suboptimal B5 intake impairs cortisol production capacity — paradoxically, in the early hypercortisol phase of dysregulation this seems counterproductive, but B5 optimization improves overall HPA resilience and stress recovery kinetics. Food sources are excellent (liver, sunflower seeds, mushrooms) but supplementation is warranted in the setting of confirmed HPA dysregulation.
Exercise and HPA Axis Recovery
Exercise is simultaneously one of the most powerful interventions for HPA axis restoration and one of the most common causes of HPA dysregulation when misapplied. The key principle: exercise type, intensity, and volume must match current HPA capacity — and that capacity must be assessed before prescribing exercise as medicine.
In HPA axis dysregulation with confirmed low morning cortisol and blunted CAR — the advanced stage with flat or inverted curve — high-intensity exercise (HIIT, CrossFit, competitive sports, distance running) acts as a powerful HPA stressor that perpetuates the dysregulation. The cortisol spike from high-intensity exercise adds to an already overwhelmed system. For these patients, high-intensity exercise restriction is often counterintuitive but essential for recovery, typically for 4-8 weeks minimum.
Zone 2 aerobic training — sustainable aerobic exercise at 60-70% maximum heart rate, the first lactate threshold — is the ideal exercise modality for HPA recovery. It is anti-inflammatory (reduces IL-6 and CRP), mitochondria-supportive (PGC-1α activation without major cortisol spike), mood-improving (endorphin and BDNF release), and sleep-promoting without adding to cortisol burden. The target for HPA recovery is 150-180 minutes per week of Zone 2, distributed across 4-5 sessions, with no sessions exceeding 45 minutes initially. As HPA markers normalize (improved morning cortisol, improved CAR, improved DHEA-S), higher-intensity sessions can be reintroduced gradually using the 80/20 polarized training model.
Resistance training is compatible with HPA recovery when intensity is moderate (60-70% 1RM, RPE 6-7/10) and session length is kept under 45-50 minutes. Brief, intense resistance sessions produce a large cortisol spike; longer, moderate sessions produce smaller cortisol responses. The priority is maintaining lean muscle mass and insulin sensitivity without adding to cortisol burden.
Timeline and Monitoring
HPA axis restoration is a 3-12 month process depending on the severity and duration of dysregulation. A realistic timeline: in the first 4-6 weeks, circadian anchoring, blood sugar stabilization, and sleep optimization produce the most rapid improvements — patients typically notice better sleep quality, reduced afternoon crash severity, and improved morning function. At 8-12 weeks, adaptogen effects are fully established, cognitive function improves, and immune resilience increases. At 3-6 months, repeat 4-point salivary cortisol testing typically shows normalized diurnal curve. Full metabolic recovery — normalized DHEA-S, restored sex hormone balance, improved insulin sensitivity — may take 6-12 months.
Key monitoring markers at 3 and 6 months: 4-point salivary cortisol (objective curve normalization); DHEA-S (should rise as HPA reserve restores); fasting insulin and HOMA-IR (improved as cortisol-driven insulin resistance resolves); inflammatory markers hs-CRP and IL-6 (both decline with cortisol normalization); and subjective symptom scoring using validated tools like the Perceived Stress Scale (PSS-10) and Pittsburgh Sleep Quality Index (PSQI). The combination of objective and subjective markers provides the clearest picture of recovery trajectory.
Frequently Asked Questions
Is adrenal fatigue a real diagnosis?
The symptom pattern is real and well-documented in the scientific literature under terms including HPA axis dysregulation, burnout syndrome, allostatic overload, and hypothalamic-pituitary-adrenal blunting. What is not real is the popular conception of “adrenal glands that are tired and depleted” — actual adrenal insufficiency (Addison’s disease) is a distinct, serious autoimmune condition diagnosed by ACTH stimulation testing. HPA axis dysregulation is better understood as a neuroendocrine recalibration to chronic stress exposure — the axis adapts (maladapts) to sustained overwhelm by reducing its responsiveness. This is a real, measurable physiological state that responds to targeted intervention.
How long does HPA axis recovery take?
Most patients with moderate HPA dysregulation (6-24 months of chronically high stress, intact sleep with some disruption, no serious underlying pathology) experience meaningful improvement in energy, sleep, and stress resilience within 8-12 weeks of implementing the full protocol. Objective markers — salivary cortisol curve normalization, DHEA-S restoration — typically require 3-6 months. Severe or prolonged dysregulation (years of burnout, significant sleep deprivation, autoimmune comorbidities) may require 6-12 months. Recovery is non-linear — patients often report feeling worse in weeks 2-4 as the nervous system recalibrates, followed by rapid improvement.
Can DHEA supplementation help adrenal recovery?
DHEA supplementation can be appropriate when DHEA-S is confirmed low by testing (below 100-150 mcg/dL in women under 50, below 200 mcg/dL in men under 50). The typical starting dose is 5-25mg/day for women (DHEA converts to androgens and can cause acne, oily skin, and hair loss at higher doses) and 25-50mg/day for men. DHEA should not be supplemented without confirmed deficiency by lab testing — in people with normal DHEA-S, exogenous DHEA can suppress endogenous production. Retest at 8-12 weeks to confirm levels are optimizing. DHEA-S above 350 mcg/dL in women is not a target — overshoot risks androgenic side effects.
What is the best test for adrenal function?
The 4-point salivary cortisol test is the most clinically useful starting point — it maps the full diurnal cortisol curve at waking, noon, afternoon, and bedtime, revealing the pattern of dysregulation rather than just a snapshot number. DUTCH Complete urine testing adds cortisol metabolites (total production), cortisol awakening response, and concurrent sex hormone and DHEA assessment in one test. For cost-effectiveness, begin with DHEA-S serum (inexpensive, available through any lab) and a home 4-point saliva kit. DUTCH is the comprehensive option when full hormonal picture is needed. A single morning serum cortisol, while standard in conventional medicine, is insufficient to diagnose or monitor HPA axis dysregulation.
HPA axis dysregulation underlies many of the most common and treatment-resistant chronic health complaints — fatigue, insomnia, anxiety, metabolic dysfunction, hormonal imbalance, and immune dysregulation. If you’re experiencing the symptom pattern described in this article and want comprehensive HPA axis testing including 4-point salivary cortisol, DHEA-S, and a personalized restoration protocol, Dr. Tom Biernacki and the team at The Private Practice are available for functional medicine consultations. Call (810) 206-1402 to schedule your evaluation and begin the systematic, root-cause approach to stress resilience and hormonal health.